News
Gain key insights from Lisata Therapeutics' Q1 2025 earnings call, including clinical updates on Certepetide, strategic milestones, and robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results